Health Care & Life Sciences » Pharmaceuticals | Provectus Biopharmaceuticals Inc.

Provectus Biopharmaceuticals Inc.

Provectus Biopharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$26.92 M
Shares Outstanding
384.62 M
Public Float
368.35 M

Profile

Address
10025 Investment Drive
Knoxville Tennessee 37932
United States
Employees -
Website http://www.provectusbio.com
Updated 07/08/2019
Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treats several life threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A.

Financials

View All

Bruce Horowitz
Director
Edward V. Pershing
Chairman